Document is current

Article History

Received: 26 March 2024

Accepted: 25 July 2024

First Online: 15 August 2024

Declarations

:

: Clinical studies were conducted in accordance with the Rules of Good Clinical Practice and the revised Declaration of Helsinki for Biomedical Research with Human Subjects. All subjects had no prior history of hypersensitivity or related reactions to steroid drugs and were physically normal. In addition, healthy adults aged 19–55 years have no history of digestive, liver, kidney, cardiovascular, central nervous system, endocrine, or blood diseases in the past, and have not been taking any other drugs. All subjects underwent a physical examination, clinical screening, complete blood count, urinalysis, and blood chemistry analyzes prior to participation in this clinical study to confirm their physical health.

: All subjects provided written informed consent prior to their participation in bioequivalence and pharmacokinetic studies.

: All data were anonymized and participants were informed that the results of this study may be subject to publication and presentation in meetings.

: The authors have no conflicts of interest relevant to this study to disclose.